drugset / Trial / NCT01725048

Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer

NCT01725048

Phase 0 Completed 21 enrolled UNC Lineberger Comprehensive Cancer Center
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

This is a pilot study to test the hypothesis that the antidepressants mirtazapine and citalopram are effective treatment for major depressive disorder (MDD) in cancer patients.

Timeline

Start
2011-01
Primary completion
2012-05
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule 40 mg Oral
Comparator Mirtazapine Other / unclassified 30 mg Oral